CLINICAL TRIALS PROFILE FOR ALBIGLUTIDE
✉ Email this page to a colleague
All Clinical Trials for ALBIGLUTIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00518115 ↗ | Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only | Completed | GlaxoSmithKline | Phase 2 | 2007-04-01 | This study is a placebo-controlled study in patients with Type 2 Diabetes Mellitus who are either taking no diabetes medication or who are taking metformin only. This study will investigate the safety, tolerability, and efficacy of Albiglutide (GSK716155) and will measure the levels of Albiglutide (GSK716155) in the bloodstream when it is given for 16 weeks. As a comparison, some subjects will receive exenatide instead of Albiglutide (GSK716155). The study will involve weekly visits for 17 weeks,and less frequent follow-up visits for an additional 10 weeks. Assessments include repeat blood sampling and monitoring of any side effects. |
NCT00838903 ↗ | Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes | Completed | GlaxoSmithKline | Phase 3 | 2009-02-01 | The purpose of this study is to determine if albiglutide is safe and effective in the treatment of type 2 diabetes. |
NCT00838916 ↗ | A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes | Completed | GlaxoSmithKline | Phase 3 | 2009-02-01 | A study to determine the safety and efficacy of albiglutide in subjects with type 2 diabetes. |
NCT00839527 ↗ | A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes | Completed | GlaxoSmithKline | Phase 3 | 2009-02-01 | The purpose of this study is to determine the safety and efficacy of albiglutide in subjects with type 2 diabetes |
NCT00849056 ↗ | Safety and Efficacy of Albiglutide in Type 2 Diabetes | Completed | GlaxoSmithKline | Phase 3 | 2009-01-01 | The purpose of this study is to determine the safety, tolerability and efficacy of albiglutide in the treatment of type 2 diabetes. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ALBIGLUTIDE
Condition Name
Clinical Trial Locations for ALBIGLUTIDE
Trials by Country
Clinical Trial Progress for ALBIGLUTIDE
Clinical Trial Phase
Clinical Trial Sponsors for ALBIGLUTIDE
Sponsor Name